Received Feb 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis and PNEUMOCOCCAL VACCINE for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine, RSV vaccine and PNEUMOCOCCAL VACCINE. On an unknown date, an unknown time after receiving Shingles vaccine and RSV vaccine and an unknown time after receiving PNEUMOCOCCAL VACCINE, the patient experienced sickness (Verbatim: sick). The outcome of the sickness was resolved (duration 3 days). It was unknown if the reporter considered the sickness to be related to Shingles vaccine and RSV vaccine. It was unknown if the company considered the sickness to be related to Shingles vaccine and RSV vaccine. Additional Information: GSK Receipt date: 21-FEB-2026. This case was reported by a patient via interactive digital media. The patient received the shingles vaccine, pneumonia and RSV vaccines. The patient was sick for 3 days. The batch number was not provided, and we are unable to contact the reporter.